drugset / Trial / NCT04386707
Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to evaluate the lot consistency, immunogenicity and safety of three lots of Sabin strain inactivated polio vaccine (Vero Cell) (sIPV) manufactured at commercial scale by Sinovac Biotech Co., Ltd., and evaluate the non-inferiority of investigational vaccine against a post-market inactivated polio vaccine.
Timeline
- Start
- 2020-05-11
- Primary completion
- 2020-05-11
- Completion
- 2020-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sabin strain inactivated polio vaccine (Vero Cell) | Vaccine | — | — |
| Comparator | Wild strain IPV | Vaccine | — | — |